Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature

SIMPLE SUMMARY: Breast cancer is a leading cause of female cancer-related death worldwide. Anti-HER2-targeted therapies dramatically improved prognosis for HER2-positive breast cancer patients. Despite that, growing drug resistance due to the pressure of therapy is relatively frequent. For that reas...

Descripción completa

Detalles Bibliográficos
Autores principales: Isca, Chrystel, Piacentini, Federico, Mastrolia, Ilenia, Masciale, Valentina, Caggia, Federica, Toss, Angela, Piombino, Claudia, Moscetti, Luca, Barbolini, Monica, Maur, Michela, Dominici, Massimo, Omarini, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508299/
https://www.ncbi.nlm.nih.gov/pubmed/34638377
http://dx.doi.org/10.3390/cancers13194894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508299/
https://www.ncbi.nlm.nih.gov/pubmed/34638377
http://dx.doi.org/10.3390/cancers13194894

Ejemplares similares